Skip to content
Lower risk Medical device recall · FDA · Published September 21, 2018

DePuy CORAIL Hip Implant Recall: Debris Risk in Neck Trials

DePuy recalls certain CORAIL hip implants due to potential debris behind O-rings. Affected models include specific lot numbers for hip surgery instruments. Contact DePuy for details.

🇺🇸 FDA recall #Z-1127-2019Medical deviceDePuy ›
Take action

Contact the company

Recalling firmDePuy Orthopaedics, Inc.700 Orthopaedic Dr · Warsaw, IN 46582-3994
✎ GovInfoNow plain-language explainer

DePuy is recalling specific hip implants that may have debris behind the O-rings, which could cause complications during surgery. This recall affects certain lot numbers of the CORAIL AMT STANDARD OFFSET NECK SEGMENT (STD) used in hip replacements. Read more at govinfonow.com/recall/69831-depuy-corail-hip-implant-recall-debris-risk-in-neck-trials.

Source Summary by GovInfoNow · govinfonow.com/recall/69831-depuy-corail-hip-implant-recall-debris-risk-in-neck-trials · Updated August 20, 2026 · FDA enforcement record: FDA #Z-1127-2019

Cite this page

“DePuy CORAIL Hip Implant Recall: Debris Risk in Neck Trials.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/69831-depuy-corail-hip-implant-recall-debris-risk-in-neck-trials. Based on FDA recall #Z-1127-2019 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1127-2019%22&limit=1).

The FDA announced on September 21, 2018, that DePuy Orthopaedics, Inc. voluntarily recalled CORAIL AMT STANDARD OFFSET NECK SEGMENT (STD) neck trials due to potential debris behind O-rings. The recall affects 12,639 units distributed worldwide and in the United States.

How to tell if you have it

  • Brand: DePuy
  • Product: CORAIL AMT STANDARD OFFSET NECK SEGMENT (STD), Pro. Code L20431
  • Lots: 1212901, 1218481, 1226220, 1230761, 1230762, 1700575, 1781381, 1812714, 1817780, 1860264, 1865892, 1874689, 1874692, 1874695, 1885306, 1899212, 1899213, 1910187, 1979239, 2002010, 2024019, 2043428, 2078239, 2102693, 2129111, 2153317, 2153318, 2153319, 2153320, 2163174, 2249115, 2249116, 2252364, 2274452, 2275487, 2284306, 2284307, 2309644, 2309645, 2309646, 2336389, 2336390, 2362086, 2362087, 2380243, 2384473, 2384474, 2386339, 2401664, 2401665, 2416615, 2416617, 2416618, 2465273, 2465274, 2465275, 2465287, 2490513, 2490514, 2513465, 2513466, 2526363, 2526364, 2539884, 2539885, 2565583, 2572825, 2572826, 2602513, 2602514, 2605764, 2605765, 2643408, 2643409, 2648066, 2648067, 2673433, 2673434, 2691497, 2691501, 2739089, 2739090, 2749282, 2749283, 2774407, 2774408, 2774409, 2774410, 2795717, 2795718, 2795719, 2811227, 2811228, 2811233, 2811234, 2836707, 2836708, 2836709, 5001519, 5001520, 5001521, 5001522, 5005846, 5005847, 5008238, 5008239, 5009208, 5016192, 5016193, 5016194, 5016195, 5016196, 5019838, 5019841, 1812714A

The hazard

According to the FDA, there is the potential for debris or material to be found behind the O-rings in the neck trials. The affected products are surgical instruments used in CORAIL total and partial hip arthroplasty.

Context

GovInfoNow's records show DePuy Orthopaedics, Inc. has 23 other recalls on record since July 12, 2017. Other recent recalls of similar products include ATTUNE Knee Component Due to Incorrect Labeling (March 12, 2024), Attune Revision Limb Preservation Tibial Insert XSM 26MM Recall (February 15, 2023), and ATTUNE Sizing Guide Recall (June 29, 2022). Other recent recalls of similar products include Depuy ATTUNE Revision Hinge Femoral LT SZ 5 CEM, Depuy ATTUNE Revision Hinge Femoral LT SZ 8 CEM, and Depuy ATTUNE Revision Hinge Femoral RT SZ 3 CEM (April 3, 2026).

How to tell if you have this one

Check for the product name 'CORAIL AMT STANDARD OFFSET NECK SEGMENT (STD)' with the specific lot numbers listed in the recall notice. These are used in hip replacement surgeries.

  • Brand
    DePuy
  • Category
    Medical device
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Worldwide Distribution - US Nationwide Distributed to accounts in AL AZ CA CO FL GA HI IA IL IN KY LA MA MD ME MI MN MS NC ND NH NJ NV NY OH OR PA SC TN TX UT VA WA, and WI. International distribution worldwide.
Recall numberProduct, codes & lots
Z-1127-2019CORAIL AMT STANDARD OFFSET NECK SEGMENT (STD), Pro. Code L20431 Product Usage: The affected CORAIL Neck Trials are surgical instruments used in CORAIL total and partial hip arthroplasty.; lots 1212901 1218481 1226220 1230761 1230762 1700575 1781381 1812714 1817780 1860264 1865892 1874689 1874692 1874695 1885306 1899212 1899213 1910187 1979239 2002010 2024019 2043428 2043428 2078239 2078239 2102693 2102693 2129111 2129111 2153317 2153317 2153318 2153318 2153319 2153319 2153320 2153320 2163174 2163174 2249115 2249116 2252364 2274452 2275487 2284306 2284307 2309644 2309645 2309646 2336389 2336390 2362086 2362087 2380243 2384473 2384474 2386339 2401664 2401665 2416615 2416617 2416618 2465273 2465274 2465275 2465287 2490513 2490514 2513465 2513466 2526363 2526364 2539884 2539885 2565583 2572825 2572826 2602513 2602514 2605764 2605765 2643408 2643409 2648066 2648067 2673433 2673434 2691497 2691501 2739089 2739090 2749282 2749283 2774407 2774408 2774409 2774410 2795717 2795718 2795719 2811227 2811228 2811233 2811234 2836707 2836708 2836709 5001519 5001520 5001521 5001522 5005846 5005847 5008238 5008239 5009208 5016192 5016193 5016194 5016195 5016196 5019838 5019841 1812714A 1812714A
Z-1128-2019CORAIL AMT COXA VARA NECK SEGMENT (KLA) Pro. Code L20432 Product Usage: The affected CORAIL Neck Trials are surgical instruments used in CORAIL total and partial hip arthroplasty.; 1212912 1216680 1230766 1700576 1812715 1812716 1817781 1860265 1865893 1874690 1874693 1874696 1885307 1899214 1899215 1910188 1979242 2002011 2024020 2043429 2043429 2078240 2078240 2102701 2102701 2129112 2129112 2153321 2153321 2153322 2153322 2153323 2153323 2153324 2153324 2173202 2173202 2284268 2284304 2284305 2309647 2309648 2309649 2336392 2336393 2384475 2384476 2386340 2401666 2416616 2416619 2416620 2465280 2465288 2481312 2490516 2511420 2526365 2565598 2565705 2565706 2572839 2572840 2605839 2605840 2609135 2609141 2643411 2643412 2673435 2673436 2673437 2691532 2691533 2739091 2739092 2749286 2774417 2774418 2774419 2795761 2795762 2795763 2811229 2811230 2811235 2811236 2836712 2836713 2836714 5002114 5002115 5002116 5005843 5005844 5005845 5012219 5012220 5016191 5017033 5017035 1812716A 1812716A
Z-1129-2019CORAIL AMT HIGH OFFSET NECK SEGMENT (KHO), Pro. Code L20433 Product Usage: The affected CORAIL Neck Trials are surgical instruments used in CORAIL total and partial hip arthroplasty.; 1216681 1216682 1230767 1230768 1230769 1700574 1700577 1781383 1812717 1817782 1860266 1865894 1874691 1874694 1874697 1885308 1899216 1899217 1910189 2002012 2024021 2043430 2043430 2065508 2065508 2078241 2078241 2102703 2102703 2102704 2102704 2129113 2129113 2142423 2142423 2153325 2153325 2153326 2153326 2173203 2173203 2249175 2249176 2249177 2252365 2274507 2284309 2284310 2309652 2309653 2309654 2336394 2336395 2362088 2362089 2380244 2384477 2384478 2401667 2416621 2416622 2424599 2465283 2465284 2465285 2465289 2487632 2490517 2490518 2513467 2515079 2526367 2526368 2565627 2565714 2565715 2572844 2572845 2572846 2609035 2609037 2617683 2617684 2643413 2643414 2673438 2673439 2673440 2691548 2691549 2749290 2761213 2795714 2795715 2795716 2811225 2811226 2811231 2811232 2823044 2836720 2836721 2836722 5002110 5002111 5002112 5002113 5005841 5005842 5008236 5008237 5009207 5012217 5012218 5016197 5016198 5017028 5017030 5019843 1812717A 1812717A
Based on the official FDA remedy

What to do — step by step

  1. Check Product Lot Numbers

    Identify the lot numbers from the list provided in the recall notice to determine if your hip implant is affected.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 34 states.

Alaska: nationwideAKMaine: named in the noticeMEVermont: nationwideVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: nationwideNEMissouri: nationwideMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: nationwideARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: nationwideOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “Worldwide Distribution - US Nationwide Distributed to accounts in AL AZ CA CO FL GA HI IA IL IN KY LA MA MD ME MI MN MS NC ND NH NJ NV NY OH OR PA SC TN TX UT VA WA, and WI. International distribution worldwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arizona, California, Colorado, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Sep 21, 201812. FDA classified it Class II: Apr 11, 201923. Published in FDA’s Enforcement Report: Apr 17, 201934. FDA terminated the recall: Apr 22, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1127-2019 (September 21, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1127-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA